Webcast ImageWebcast
Q4 2016 FibroGen Inc Earnings Conference Call (Live)
03/01/17 at 4:30 p.m. ET
Q4 2016 FibroGen Inc Earnings Conference Call
Wednesday, March 1, 2017 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
FGEN (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 1.40 (5.93%)
Data as of 02/27/17 4:00 p.m. ET
Refresh quote
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs.
Recent Press ReleasesMore »
02/22/17FibroGen to Report Fiscal 2016 Financial Results on March 1, 2017Printer Friendly Version
02/03/17FibroGen Announces Publication of Pamrevlumab (FG-3019) Clinical Data in Pancreatic Cancer Showing Safety and Improved Survival Outcomes in Combination with ChemotherapyPrinter Friendly Version
01/30/17FibroGen’s Roxadustat (FG-4592) Meets Primary Endpoints in Two Phase 3 Anemia Studies in ChinaPrinter Friendly Version
01/20/17Pamrevlumab Pancreatic Cancer Clinical Data Presented at ASCO 2017 Gastrointestinal Cancers SymposiumPrinter Friendly Version
Upcoming EventsMore »
03/01/17 4:30 p.m. ET
Q4 2016 FibroGen Inc Earnings Conference Call
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources